IndiGo co-founder Rakesh Gangwal pledges Rs 100 cr to alma mater IIT Kanpur


Table of Contents

In one of the largest private donations made to an educational entity, Co-founder Rakesh Gangwal has pledged to donate Rs 100 crore to his alma mater Indian Institute of Technology (IIT), Kanpur, to establish a medical school on the campus.

The agreement was signed between the institute and Gangwal on Monday to support the flagship medical project. The proposed school will be named ‘Gangwal School of Medical Sciences and Technology’ where he will join its Advisory Board.

“The proposed medical school will play an important role in driving IIT Kanpur’s innovations in medical research and technology and catapult India into the global league of institutions that are converging medical sciences and technology to benefit humankind,” said Director Abhay Karandikar.

“I am proud to see the institution that has produced thousands of leaders across various sectors, is now paving the way in the . More than ever, healthcare is intertwined with technological advances and this school will accelerate innovation in healthcare,” Gangwal noted.

With this development, will converge its technology and innovation capabilities with medical sciences to catapult the institute into the league of global institutions. This will be achieved through the Centers of Excellence (CoE) on futuristic medicine and a super-specialty hospital.

The proposed institution will be completed in two phases. Phase I of the project will include a 500-bed super-specialty hospital, academic block, residential/hostel, and service block with a total built-up area of 810,000 sq ft., which will include setting up CoE for R&D as well. This phase is tentatively planned to be completed over the next 3-5 years.

Phase II will see the hospital capacity grow to 1,000 beds, expand in clinical departments, research areas, the inclusion of paramedical disciplines, alternative medicine, hospital management, sports medicine, and public health programmes over a period of 7-10 years.

Dear Reader,

Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.

We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor


Source link